Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

An Open-Label, Single-Dose, Non-Randomized, 4-Period Crossover Bioavailability Study of Bazedoxifene Contained in Bazedoxifene/Conjugated Estrogen Tablets Administered to Healthy Postmenopausal Women

The primary purpose is to determine bioavailability of Bazedoxifene/conjugated estrogen formulations for future testing purposes.

Inclusion Criteria:

• Healthy, post menopausal women ages 45 to 70

Exclusion Criteria:

• Male subjects